Drug intelligence / Profile preview

RecalMax

Development stage
Unknown
Lead developer
Aytu BioPharma
Modality
Small Molecules
Administration
Oral
01

Overview

RecalMax is a dietary supplement developed by Innovus Pharmaceuticals, formulated to enhance cognitive health and brain function. It consists of a proprietary blend of the amino acids L-arginine and L-citrulline, combined with Bioperine (a black pepper extract) to improve bioavailability. The supplement's primary mechanism of action involves increasing the production of nitric oxide, which acts as a vasodilator to improve cerebral blood flow. This increased circulation is intended to support memory, mental focus, and processing speed, while also mitigating symptoms of mental fatigue. RecalMax is marketed primarily to seniors and individuals concerned with cognitive decline, including those with Alzheimer's disease or dementia. It is available over-the-counter in the United States and is registered as a Natural Health Product in Canada.

Brand names
RecalMax
02

Targets

NOS1 (nNOS)NO2- (Nitrite)

Beyond the preview

Go deeper on RecalMax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RecalMax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call